Publicis Health has snapped up another Omnicom Health Group executive. | Publicis Health has snapped up another Omnicom ...

The FDA has blessed AstraZeneca and Daiichi Sankyo’s Datroway to treat patients with locally advanced or metastatic epidermal ...

For the life sciences sector, the new initiatives are meant to work in concert with the upcoming 10-year plan for the ...

Fourteen years after AstraZeneca’s blood thinner Brilinta reached the market and now faces generic competition, the data that ...

Ratio Therapeutics and Ionetix have inked separate deals to boost production of the much-needed radioisotope actinium-225, ...

In the wake of Marks' exit, FDA commissioner Marty Makary, M.D., named Vinay Prasad, M.D., to head up CBER. In addition to that title, Prasad recently added the title of "chief medical and science ...

Reckitt has selected Serena Williams as its doubles partner for a new plan to serve up support for health and hygiene startups around the world. | Reckitt has selected Serena Williams as its doubles ...

Life sciences commercial teams are drowning in data complexity. | ciATHENA eliminates the traditional barriers between ...

Roche has demonstrated the power of combining two of oncology's hottest modalities—bispecifics and antibody-drug conjugates ...

Fueled by a sustained boom in sales of its diabetes and obesity products, Eli Lilly will become the world’s top-seller of prescription drugs by 2030 and will hold the top rung by a wide margin. | ...

In the wake of Robert F. Kennedy Jr.’s abrupt revamp of the CDC’s Advisory Committee on Immunization Practices, details from ...

The FDA approval of Vimkunya has given the chikungunya vaccine’s owner, Bavarian Nordic, an extra financial windfall. | The ...